2013 Volume 31 Issue 2 Pages 27-31
The aim of the study is to evaluate the safety and effectiveness of microwave endometrial ablation (MEA) in women with submucous myomas for office-based gynecology. Thirty outpatients (average age : 44.6 years) who hoped to avoid hysterectomy received MEA for treatment of menorrhagia due to submucous myomas. The patients were divided into two groups according to the maximal myoma size. Group A (21 cases) in which node is less than 3 centimeters treated by MEA. Group B (9 cases) in which node is over 3 centimeters was treated by MEA with transcervical microwave myolysis (TCMM).
The mean operation time were in Group A; 17.7 and in Group B; 18.5 min. The blood loss during a monthly menstrual period decreased in Group A; seventeen (80.9%) and Group B; eight (88.8%) patients to less than 20%, Group A; three (14.2%) and Group B; one (11.1%) patient to less than 50%. Menorrhagia remained in Group A; one (4.7%) and in Group B; no patient after treatment. Three patients (14.2%) of Group A and one (11.1%) of Group B had mild endometritis within a month after treatment. The average VAS score regarding feelings of satisfaction for MEA were 8.8 (Group A) and 9.2 (Group B)(full score=10). MEA with TCMM is feasible for treatment of menorrhagia due to submucous myomas in various size and it may be useful for a office day surgical procedure that is minimally invasive for who hoped to avoid hysterectomy.
